Clinical Pharmacokinetics

, Volume 6, Issue 6, pp 480–480 | Cite as

Current Literature References on Clinical Pharmacokinetics



Clinical Pharmacokinetic Pethidine Cefoperazone Netilmicin Placental Transfer 


Series 6

  1. Pharmacokinetics of Thiopental in caesarian section. Heslop Christensen, J.; Andreasen, F. and Jansen, J.A.: Acta Anaesthesiologica Scandinavica 25: 174 (1981).CrossRefGoogle Scholar
  2. Neonatal depression after obstetrical analgesia with pethidine. The role of the injection — delivery time interval and of the plasma concentrations of pethidine and norpethidine. Belfrage, P.; Boreus, L.O.; Hartvig, P. et al.: Acta Obstetrica et Gynaecologica Scandinavica 60: 43 (1981).CrossRefGoogle Scholar
  3. Persistence of ampicillin in the intrauterine content following single and multiple doses to pregnant women. Philipson, A.: Acta Obstetrica et Gynaecologica Scandinavica 60: 121 (1981).Google Scholar
  4. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics. Munch, E.P.; Sondergaard, J. and Meeke, B.: Allergy 36: 89 (1981).PubMedCrossRefGoogle Scholar
  5. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders. Somani, P.: American Journal of Cardiology 48: 157 (1981).PubMedCrossRefGoogle Scholar
  6. Theophylline pharmacokinetics. Kadlec, G.J.; Jarboe, C.H.; Pollard, S.J. et al.: American Journal of Diseases of Children 135: 82 (1981).PubMedGoogle Scholar
  7. Gentamicin-induced ototoxicity in a carefully monitored renal-failure patient. Crass, R.E.: American Journal of Hospital Pharmacy 38: 540 (1981).PubMedGoogle Scholar
  8. Use of pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm. Pancorbo, S.; Davies, S. and Raymond, J.L.: American Journal of Hospital Pharmacy 38: 851 (1981).PubMedGoogle Scholar
  9. Placental transfer of methylprednisolone following maternal intravenous administration. Anderson, G.G.; Rotchell, Y. and Kaiser, D.G.: American Journal of Obstetrics and Gynecology 140: 699 (1981).PubMedGoogle Scholar
  10. Influence of co-trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia. Beach, B.J.; Woods, W.G. and Howell, S.B.: American Journal of Pediatric Hematology/Oncology 3: 115 (1981).PubMedCrossRefGoogle Scholar
  11. Effect of alcohol consumption and cigarette smoking on anti-depressant levels of depressed patients. Linnoila, M.; George, L.; Guthrie, S. et al.: American Journal of Psychiatry 138: 841 (1981).PubMedGoogle Scholar
  12. Caesarean section and placental transfer of alvuronium. Ho, P.C.; Stephens, I.D. and Triggs, E.J.: Anaesthesia and Intensive Care 9: 113 (1981).PubMedGoogle Scholar
  13. Removal of tobramycin during plasma exchange therapy. Appelgate, R.; Schwartz, D. and Bennett, W.M.: Annals of Internal Medicine 94: 820 (1981).PubMedGoogle Scholar
  14. Low blood levels of phenobarbital due to poor gastrointestinal solubility of phenobarbital tablets. Alvarez, N.; Hartford, E. and Cavalleri, E.: Annals of Neurology 9: 309 (1981).PubMedCrossRefGoogle Scholar
  15. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. Patamasucon, P.; Kaojarern, S.I.; Kusmiesz, H. et al.: Antimicrobial Agents and Chemotherapy 19: 736 (1981).PubMedCrossRefGoogle Scholar
  16. Intrarenal concentrations of ampicillin in acute pyelonephritis. Trottier, S. and Bergeron, M.G.: Antimicrobial Agents and Chemotherapy 19: 761 (1981).PubMedCrossRefGoogle Scholar
  17. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Kline Bolton, W.; Scheid, W.M.; Spyker, D.A. et al.: Antimicrobial Agents and Chemotherapy 19: 821 (1981).CrossRefGoogle Scholar
  18. Pharmacokinetics of Moxalactam in subjects with normal and impaired renal function. Leroy, A.; Humbert, G. and Fillastre, J.P.: Antimicrobial Agents and Chemotherapy 19: 965–971 (1981).PubMedCrossRefGoogle Scholar
  19. Pharmacokinetics of netilmicin in children with and without cystic fibrosis. Michalsen, H. and Bergan, T.: Antimicrobial Agents and Chemotherapy 19: 1029–1031 (1981).PubMedCrossRefGoogle Scholar
  20. Pharmacokinetics of cefoperazone in patients with neoplastic disease. Maksymiuk, A.W.; LeBlanc, B.M.; Brown, N.S. et al.: Antimicrobial Agents and Chemotherapy 19: 1037–1041 (1981).PubMedCrossRefGoogle Scholar
  21. Comparative pharmacokinetics of Cyclacillin and Amoxacillin in infants and children. Ginsburg, C.M.; McCracken, G.H. Jr; Ginsburg, C.M. et al.: Antimicrobial Agents and Chemotherapy 19: 1086–1088 (1981).PubMedCrossRefGoogle Scholar
  22. Penetration into human urogenital tissues, muscle tissues, rib and cerebrospinal fluid of thiamphenicol. Plomp, T.A.; Schalkhäuser, K.M. and Maes, R.A.: Arzneimittel-Forschung 31: 1165 (1981).PubMedGoogle Scholar
  23. Drugs and liver disease. Schencker, S.: Australian and New Zealand Journal of Medicine 11: 219 (1981).Google Scholar

Copyright information

© ADIS Press Australasia Pty Ltd. 1981

Personalised recommendations